Literature DB >> 24055517

Isolation and antiproliferative activity of Lotus corniculatus lectin towards human tumour cell lines.

Shaista Rafiq1, Rabiya Majeed, Asif Khurshid Qazi, Bashir Ahmad Ganai, Ishfak Wani, Syed Rakhshanda, Yasrib Qurishi, P R Sharma, Abid Hamid, Akbar Masood, Rabia Hamid.   

Abstract

The objective of the study was to investigate the anti cancer activity of a lectin isolated from Lotus corniculatus seeds. A tetrameric 70kDa galactose specific lectin was purified using two step simple purification protocol which involved affinity chromatography on AF-BlueHC650M and gel filtration on Sephadex G-100. The lectin was adsorbed on AF-BlueHC650M and desorbed using 1M NaCl in the starting buffer. Gel filtration on Sephadex G-100 yielded a major peak absorbance that gave two bands of 15kDa and 20kDa in SDS PAGE. Hemagglutination activity was completely preserved, when the temperature was in the range of 20-60°C. However, drastic reduction in activity occurred at temperatures above 60°C. Full hemagglutination activity was retained at ambient pH 4-12. Thereafter no activity was observed above pH 13. Hemaglutination of the lectin was inhibited by d-galactose. The lectin showed a strong antiproliferative activity towards human leukemic (THP-1) cancer cells followed by lung cancer (HOP62) cells and HCT116 with an IC50 of 39μg/ml and 50μg/ml and 60μg/ml respectively. Flow cytometry analysis showed an increase in the percentage of cells in sub G0G1 phase confirming that Lotus corniculatus lectin induced apoptosis. Morphological observations showed that Lotus corniculatus lectin (LCL) treated THP-1 cells displayed apparent apoptosis characteristics such as nuclear fragmentation, appearance of membrane enclosed apoptotic bodies and DNA fragmentation. Lotus corniculatus lectin (LCL) effectively inhibits the cell migration in a dose dependent manner as indicated by the wound healing assay.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Antiproliferative; Human leukemic cancer cells; Lotus corniculatus lectin (LCL); d-Galactose binding

Mesh:

Substances:

Year:  2013        PMID: 24055517     DOI: 10.1016/j.phymed.2013.08.005

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  A Glucosamine-Specific Lectin from Green Dragon No. 8 Beans (Phaseolus vulgaris) Induced Apoptosis on Nasopharyngeal Carcinoma Cells.

Authors:  Yau Sang Chan; Lixin Xia; Tzi Bun Ng
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-28       Impact factor: 2.629

Review 2.  Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications.

Authors:  Luana Cassandra Breitenbach Barroso Coelho; Priscila Marcelino Dos Santos Silva; Vera Lúcia de Menezes Lima; Emmanuel Viana Pontual; Patrícia Maria Guedes Paiva; Thiago Henrique Napoleão; Maria Tereza Dos Santos Correia
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-07       Impact factor: 2.629

3.  Anti-inflammatory and Antioxidant Effects of Lotus corniculatus on Paracetamol-induced Hepatitis in Rats.

Authors:  Nacera Baali; Abderahmane Mezrag; Mohamed Bouheroum; Fadila Benayache; Samir Benayache; Amedah Souad
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020

4.  A New Galactose-Specific Lectin from Clerodendrum infortunatum.

Authors:  Sukumaran Surya; Madhathilkovilakathu Haridas
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

5.  Biochemical characterisation of lectin from Indian hyacinth plant bulbs with potential inhibitory action against human cancer cells.

Authors:  Sanjay Naik; Ravindra Singh Rawat; Santripti Khandai; Mukesh Kumar; Sidhartha S Jena; Mookambeswaran A Vijayalakshmi; Sanjit Kumar
Journal:  Int J Biol Macromol       Date:  2017-08-07       Impact factor: 6.953

Review 6.  Research advances and prospects of legume lectins.

Authors:  Rajan Katoch; Ankur Tripathi
Journal:  J Biosci       Date:  2021       Impact factor: 1.826

Review 7.  Plant Lectins as Medical Tools against Digestive System Cancers.

Authors:  Laura Elena Estrada-Martínez; Ulisses Moreno-Celis; Ricardo Cervantes-Jiménez; Roberto Augusto Ferriz-Martínez; Alejandro Blanco-Labra; Teresa García-Gasca
Journal:  Int J Mol Sci       Date:  2017-07-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.